Treatment Response in First-episode Schizophrenia

키워드

참고문헌 (80)

1. Frangou S, "How to manage the first episode of schizophrenia", BMJ, 321, pp.522~523 (2000)
2. Redmond C, "The personal meaning of romantic relationships for young people with psychosis", Clin Child Psychol Psychiatry, 15, pp.151~170 (2010)
3. Schnabel R, "Predisposing factors for early retirement in patients with schizophrenia in Germany", Eur J Health Econ, 9, pp.265~274 (2008)
4. Harrison G, "Recovery from psychotic illness: a 15- and 25-year international follow-up study", Br J Psychiatry, 178, pp.506~517 (2001)
5. Loebel AD, "Duration of psychosis and outcome in first-episode schizophrenia", Am J Psychiatry, 149, pp.1183~1188 (1992)
6. International Early Psychosis Association Writing Group, "International clinical practice guidelines for early psychosis", Br J Psychiatry Suppl, 48, pp.s120~s124 (2005)
7. Lambert M, "Management of incomplete remission and treatment resistance in first-episode psychosis", Expert Opin Pharmacother, 9, pp.2039~2051 (2008)
8. Jäger M, "Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders", Eur Arch Psychiatry Clin Neurosci, 257, pp.47~53 (2007)
9. Falkai P, "WFSBP Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia", World J Biol Psychiatry, 6, pp.132~191 (2005)
10. Robinson DG, "Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder", Am J Psychiatry, 156, pp.544~549 (1999)
11. Emsley R, "Time course for antipsychotic treatment response in first-episode schizophrenia", Am J Psychiatry, 163, pp.743~745 (2006)
12. Birchwood M, "Early intervention in psychosis. The critical period hypothesis", Br J Psychiatry Suppl, 172, pp.53~59 (1998)
13. McGlashan TH, "A selective review of recent North American long-term followup studies of schizophrenia", Schizophr Bull, 14, pp.515~542 (1988)
14. Leucht S, "Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia", J Clin Psychiatry, 67, pp.1813~1814 (2006)
15. Leucht S, "Defining ‘response’ in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs", Neuropsychopharmacology, 32, pp.1903~1910 (2007)
16. Lieberman J, "Time course and biologic correlates of treatment response in first-episode schizophrenia", Arch Gen Psychiatry, 50, pp.369~376 (1993)
17. Emsley RA, "Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study", Schizophr Bull, 25, pp.721~729 (1999), Risperidone Working Group
18. Sanger TM, "Olanzapine versus haloperidol treatment in first-episode psychosis", Am J Psychiatry, 156, pp.79~87 (1999)
19. Agid O, "Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected", Arch Gen Psychiatry, 60, pp.1228~1235 (2003)
20. Leucht S, "Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended", Biol Psychiatry, 57, pp.1543~1549 (2005)
21. Kinon BJ, "Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia", Schizophr Res, 102, pp.230~240 (2008)
22. Kinon BJ, "Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia", Neuropsychopharmacology, 35, pp.581~590 (2010)
23. Derks EM, "Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?", J Clin Psychopharmacol, 30, pp.176~180 (2010), EUFEST Study Group
24. Gallego JA, "Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?", J Clin Psychiatry, 72, pp.1691~1696 (2011)
25. Schennach-Wolff R, "An early improvement threshold to predict response and remission in first-episode schizophrenia", Br J Psychiatry, 196, pp.460~466 (2010)
26. Schennach R, "Should early improvement be re-defined to better predict the maintenance of response in FES patients?", Acta Psychiatrica Scandinavic (2012)
27. Silvestri S, "Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study", Psychopharmacology, 152, pp.174~180 (2000)
28. Deng MY, "A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia", Psychopharmacology, 206, pp.437~446 (2009)
29. Dolzan V, "Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1562~1566 (2008)
30. Rasmussen H, "Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine", Psychopharmacology, 213, pp.583~592 (2011)
31. Ikeda M, "Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia", Pharmacogenomics, 9, pp.1437~1443 (2008)
32. Lencz T, "DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients", Am J Psychiatry, 163, pp.529~531 (2006)
33. Pelayo-Terán JM, "Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis", Psychiatry Res, 185, pp.286~289 (2011)
34. Kapur S, "Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia", Am J Psychiatry, 157, pp.514~520 (2000)
35. Szeszko PR, "Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia", Schizophr Bull, 38, pp.569~578 (2012)
36. Garner B, "Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients", Schizophr Res, 113, pp.65~71 (2009)
37. Belvederi Murri M, "Hypothalamic-pituitaryadrenal axis and clinical symptoms in first-episode psychosis", Psychoneuroendocrinology, 37, pp.629~644 (2012)
38. van Venrooij JA, "Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis", Schizophr Bull, 38, pp.272~279 (2012)
39. Merlo MC, "Differences in the EEG profiles of early and late responders to antipsychotic treatment in first-episode, drug-naive psychotic patients", Schizophr Res, 30, pp.221~228 (1998)
40. McGlashan TH, "Duration of untreated psychosis in firstepisode schizophrenia: marker or determinant of course?", Biol Psychiatry, 46, pp.899~907 (1999)
41. Norman RM, "Duration of untreated psychosis: a critical examination of the concept and its importance", Psychol Med, 31, pp.381~400 (2001)
42. Addington J, "Duration of untreated psychosis: impact on 2-year outcome", Psychol Med, 34, pp.277~284 (2004)
43. de Haan L, "Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication", Schizophr Bull, 29, pp.341~348 (2003)
44. Bottlender R, "The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia", Schizophr Res, 62, pp.37~44 (2003)
45. Larsen TK, "Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis", Schizophr Res, 45, pp.1~9 (2000)
46. Crespo-Facorro B, "Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables", J Psychiatr Res, 41, pp.659~666 (2007)
47. Verdoux H, "Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients", Schizophr Res, 49, pp.231~241 (2001)
48. Perkins D, "Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders", Br J Psychiatry, 185, pp.18~24 (2004), HGDH Research Group.
49. Schimmelmann BG, "Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort", J Psychiatr Res, 42, pp.982~990 (2008)
50. CeskováE, "Psychopathology and treatment responsiveness of patients with first-episode schizophrenia", Neuropsychiatr Dis Treat, 1, pp.179~185 (2005)
51. Addington J, "Symptom outcome 1 year after admission to an early psychosis program", Can J Psychiatry, 48, pp.204~207 (2003)
52. Schennach-Wolff R, "Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?", Eur Neuropsychopharmacol, 21, pp.370~378 (2011)
53. Drake RJ, "Insight as a predictor of the outcome of firstepisode nonaffective psychosis in a prospective cohort study in England", J Clin Psychiatry, 68, pp.81~86 (2007)
54. Prikryl R, "Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia", Eur Psychiatry, 22, pp.499~504 (2007)
55. Oosthuizen P, "A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis", Int J Neuropsychopharmacol, 7, pp.125~131 (2004)
56. Robinson DG, "Pharmacological treatments for first-episode schizophrenia", Schizophr Bull, 31, pp.705~722 (2005)
57. Kinon BJ, "Mechanisms of action of atypical antipsychotic drugs: a critical analysis", Psychopharmacology, 124, pp.2~34 (1996)
58. Mö€ller HJ, "Management of the negative symptoms of schizophrenia: new treatment options", CNS Drugs, 17, pp.793~823 (2003)
59. Mö~ller HJ, "State of the art of drug treatment of schizophrenia and the future position of the novel", atypical antipsychotics, 2000, pp.1, 204~214
60. Lieberman JA, "Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol", Am J Psychiatry, 160, pp.1396~1404 (2003), HGDH Study Group
61. Schooler N, "Early Psychosis Global Working Group. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial", Am J Psychiatry, 162, pp.947~953 (2005)
62. Mö~ller HJ, "Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia", Int J Neuropsychopharmacol, 11, pp.985~997 (2008)
63. Kahn RS, "Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial", Lancet, 371, pp.1085~1097 (2008), EUFEST study group
64. Boter H, "Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)", Schizophr Res, 115, pp.97~103 (2009), EUFEST study group
65. Crossley NA, "Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis", Br J Psychiatry, 196, pp.434~439 (2010)
66. Rummel C, "New generation antipsychotics for first episode schizophrenia", Cochrane Database Syst Rev, 4, pp.CD004410~ (2003)
67. Lieberman JA, "Antipsychotic drug effects on brain morphology in first-episode psychosis", Arch Gen Psychiatry, 62, pp.361~370 (2005), HGDH Study Group
68. Crespo-Facorro B, "Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1936~1943 (2008)
69. National Institute for Clinical Excellence., "Schizophrenia, In NICE Clinical Guideline 82" (2009), NICE
70. Manchanda R, "Persistent psychoses in first episode patients", Schizophr Res, 80, pp.113~116 (2005)
71. Lieberman JA, "Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine", Neuropsychopharmacology, 28, pp.995~1003 (2003)
72. Woerner MG, "Clozapine as a first treatment for schizophrenia", Am J Psychiatry, 160, pp.1514~1516 (2003)
73. Agid O, "An algorithm-based approach to firstepisode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis", J Clin Psychiatry, 72, pp.1439~1444 (2011)
74. Agid O, "Early use of clozapine for poorly responding first-episode psychosis", J Clin Psychopharmacol, 27, pp.369~373 (2007)
75. Zhang ZJ, "Electroconvulsive therapy improves antipsychotic and somnographic responses in adolescents with first-episode psychosis - A case-control study", Schizophr Res, 137, pp.97~103 (2012)
76. Suzuki K, "Improvement of psychiatric symptoms after electroconvulsive therapy in young adults with intractable first-episode schizophrenia and schizophreniform disorder", Tohoku J Exp Med, 210, pp.213~220 (2006)
77. Ohlsen RI, "Clinical effectiveness in first-episode patients", Eur Neuropsychopharmacol, 14(Suppl 4), pp.S445~S451 (2004)
78. Penn DL, "Psychosocial treatment for first-episode psychosis: a research update", Am J Psychiatry, 162, pp.2220~2232 (2005)
79. Crespo-Facorro B, "Treatment of the first episode of schizophrenia: an update on pharmacologic and psychological interventions", Curr Psychiatry Rep, 10, pp.202~209 (2008)
80. Askey R, "Family work in first-onset psychosis: a literature review", J Psychiatr Ment Health Nurs, 14, pp.356~365 (2007)

관련 논문AI추천